SANOFI — Sanofi India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹73.49bn
- IN₹70.89bn
- IN₹18.37bn
Annual cashflow statement for Sanofi India, fiscal year end - December 31st, INR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 12,576 | 8,643 | 8,455 | 4,314 | 4,447 |
| Depreciation | |||||
| Non-Cash Items | -5,487 | -2,012 | -644 | 1,179 | -85 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,168 | -3,063 | -5,903 | -2,866 | -352 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,588 | 3,987 | 2,304 | 3,009 | 4,383 |
| Capital Expenditures | -230 | -222 | -343 | -364 | -257 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 6,538 | 6,731 | 718 | 172 | 144 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6,308 | 6,509 | 375 | -192 | -113 |
| Financing Cash Flow Items | -18 | -17 | -17 | -15 | -14 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -8,490 | -15,827 | -8,783 | -3,924 | -4,479 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,406 | -5,331 | -6,104 | -1,107 | -209 |